BackgroundHealthcare-associated infections (HAIs) have a major impact on public health worldwide. Particularly, hospital surfaces contaminated with bacterial pathogens are often the origin of both sporadic cases and outbreaks of HAIs. It has been demonstrated that copper surfaces reduce the microbial burden of high touch surfaces in the hospital environment. Here we report the antimicrobial characterization of a novel composite coating with embedded copper particles, named Copper Armour™.MethodsThe Copper Armour™ bactericidal activity was evaluated in in vitro assays against several bacterial pathogens, including Staphylococcus aureus, Pseudomonas aeruginosa, Escherichia coli O157:H7 and Listeria monocytogenes. Additionally, its antimicrobial properties were also evaluated in a pilot study over a nine-week period at an adult intensive care unit. For this, four high touch surfaces, including bed rails, overbed table, bedside table and IV Pole, were coated with Cooper Armour™, and its microbial burden was determined over a nine-week period.ResultsCopper Armour™ coated samples showed an in vitro reduction in bacterial burden of > 99.9% compared to control samples. Moreover, pilot study results indicate that Copper Armour™ significantly reduces the level of microbial contamination on high-touch surfaces in the hospital environment, as compared with standard surfaces.ConclusionsBased on its antimicrobial properties, Copper Armour™ is a novel self-sanitizing coating that exhibits bactericidal activity against important human pathogens and significantly reduces the microbial burden of hospital surfaces. This composite could be used as a self-sanitizing coating to complement infection control strategies in healthcare facilities.
We report the successful treatment of two patients with aneurismal subarachnoid
hemorrhage complicated by severe respiratory failure and refractory septic shock
using simultaneous prone position ventilation and high-volume hemofiltration. These
rescue therapies allowed the patients to overcome the critical situation without
associated complications and with no detrimental effects on the intracranial and
cerebral perfusion pressures. Prone position ventilation is now an accepted therapy
for severe acute respiratory distress syndrome, and high-volume hemofiltration is a
non-conventional hemodynamic support that has several potential mechanisms for
improving septic shock. In this manuscript, we briefly review these therapies and the
related evidence. When other conventional treatments are insufficient for providing
safe limits of oxygenation and perfusion as part of basic neuroprotective care in
subarachnoid hemorrhage patients, these rescue therapies should be considered on a
case-by-case basis by an experienced critical care team.
Prolonged prone position ventilation for severe respiratory distress syndrome post-pneumonectomy. Report of one case Management of patients with severe respiratory failure is mainly supportive, and protective mechanical ventilation is the pivotal treatment. When conventional therapy is insufficient to improve oxygenation without deleterious effects, other strategies should be considered. We report a 53 year-old male who presented a severe respiratory failure refractory to conventional management after pneumonectomy. Prone position ventilation was used for 36 hours. Respiratory variables improved and he did not show hemodynamic instability. He was returned to the supine position without worsening of oxygenation parameters. Extended prone position ventilation could be considered in patients presenting with unresponsive severe respiratory failure after pulmonary resection (
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.